Second-quarter earnings more than doubled at US
health-care product maker Johnson & Johnson, the company said Monday.
Quarterly net income was 3.8 billion dollars, or 1.3 dollars a share. The New Jersey-based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to 17.8 billion dollars year-on-year. Both earnings and revenue beat Wall Street's expectations, Bloomberg news reported.
Most Popular Stories
- Fed Committee Optimistic About Growth Prospects
- Pau Gasol Turns Down Lakers' Offer
- U.S.' No. 2, No. 3 Tobacco Cos in Merger Talks
- Terrific World Cup Ends with Marquee Final in Brazil
- Ex-CalPERS Chief Admits Receiving Bribes
- U.S. Immigration Courts Facing Record Backlog
- How ESPN Became a $50B Sports Empire
- Samsung Earnings Hit by Slowing China Sales
- Freshman Frustrations in Congress
- Musk Donates to Tesla Museum